Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity
- 31 March 2008
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 30 (1-2) , 99-103
- https://doi.org/10.1016/j.jaut.2007.11.014
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody–induced fetal injuryBlood, 2007
- Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) studyBlood, 2007
- Mechanisms of aPL-mediated thrombosis: Effects of aPL on endothelium and plateletsCurrent Rheumatology Reports, 2007
- Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Proceedings of the National Academy of Sciences, 2007
- Pathogenic role of anti-β2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparinHuman Reproduction Update, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- TNF-α Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy LossThe Journal of Immunology, 2005
- Pathogenic mechanisms of antiphospholipid syndrome: a new autoimmune diseaseDrug Discovery Today: Disease Mechanisms, 2004
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Published by Elsevier ,2003
- The Antiphospholipid SyndromeNew England Journal of Medicine, 2002